This biomedical company helps to develop drugs and vaccines to fight viral illnesses, such as influenza, the common cold and swine flu. Founded in 1989 by the virology professor John Oxford, Retroscreen runs clinical trials for pharmaceutical and biotechnology firms to test new antiviral compounds. It also conducts pre-clinical research, and runs virus infection studies with human volunteers under quarantine conditions. Sales have risen 66% a year from £1.1m in 2005 to £5.3m in 2008.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.